We are live on
!
Find out more
ACS
Archford Capital Strategies Portfolio holdings
AUM
$987M
1-Year Est. Return
29.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
+29.31%
3 Year Est. Return
+76.21%
5 Year Est. Return
+80.45%
10 Year Est. Return
+551.54%
AUM
$617M
AUM Growth
+$21.4M
(+3.6%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
29.88%
Holding
279
New
20
Increased
129
Reduced
75
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$4.66M |
| 2 |
Visa
V
|
+$1.89M |
| 3 |
Accenture
ACN
|
+$1.7M |
| 4 |
Ametek
AME
|
+$1.44M |
| 5 |
Apple
AAPL
|
+$1.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.69M |
| 2 |
Novartis
NVS
|
+$1.36M |
| 3 |
AbbVie
ABBV
|
+$1.27M |
| 4 |
Analog Devices
ADI
|
+$1.14M |
| 5 |
Union Pacific
UNP
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.46% |
| 2 | Healthcare | 4.55% |
| 3 | Financials | 4.21% |
| 4 | Industrials | 3.3% |
| 5 | Consumer Discretionary | 2.89% |
Similar funds
PCM
LMC
PCM
KIA
SMM
SCM
SWA
GCM
Archford Capital Strategies's Q2 2024 Portfolio in Review
As of Q2 2024, Archford Capital Strategies held 279 positions worth $617M, up 3.6% from $596M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Archford Capital Strategies's Q2 2024 filing shows 20 new, 129 increased, 75 reduced and 21 closed positions. Its largest new stake was Accenture: 5,558 shares worth $1.69M. The largest sale was Philip Morris, an estimated $1.69M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- Archford Capital Strategies's largest Q2 2024 buy was Accenture: 5,558 shares worth $1.69M.
- Archford Capital Strategies added most to iShares 0-1 Year Treasury Bond ETF in Q2 2024, an estimated $4.66M increase.
- Archford Capital Strategies's biggest Q2 2024 reduction was Philip Morris, cutting an estimated $1.69M.
- Archford Capital Strategies fully exited Novartis in Q2 2024, selling an estimated $1.36M.
- Archford Capital Strategies's ten largest holdings make up 30% of its $617M portfolio in Q2 2024.
- Archford Capital Strategies opened 20 new positions and closed 21 in Q2 2024.
- Archford Capital Strategies's portfolio value rose 3.6% quarter-over-quarter to $617M.
Based on Archford Capital Strategies's 13F filing for Q2 2024, filed 17 Jul 2024.